These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28011493)

  • 1. Podoplanin Expression in Cancer-associated Fibroblasts Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the Lung.
    Yurugi Y; Wakahara M; Matsuoka Y; Sakabe T; Kubouchi Y; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
    Anticancer Res; 2017 Jan; 37(1):207-213. PubMed ID: 28011493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma.
    Kubouchi Y; Yurugi Y; Wakahara M; Sakabe T; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
    Histopathology; 2018 Feb; 72(3):490-499. PubMed ID: 28881047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype.
    Ono S; Ishii G; Nagai K; Takuwa T; Yoshida J; Nishimura M; Hishida T; Aokage K; Fujii S; Ikeda N; Ochiai A
    Chest; 2013 Apr; 143(4):963-970. PubMed ID: 23081722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 - negative subtype.
    Tanaka Y; Ohno T; Kadonaga T; Kidokoro Y; Wakahara M; Nosaka K; Sakabe T; Suzuki Y; Nakamura H; Umekita Y
    Breast Cancer; 2021 Jul; 28(4):822-828. PubMed ID: 33481184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.
    Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
    Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma.
    Chuang WY; Yeh CJ; Chao YK; Liu YH; Chang YS; Tseng CK; Chang HK; Wan YL; Hsueh C
    Int J Clin Exp Pathol; 2014; 7(8):4847-56. PubMed ID: 25197355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer.
    Schoppmann SF; Berghoff A; Dinhof C; Jakesz R; Gnant M; Dubsky P; Jesch B; Heinzl H; Birner P
    Breast Cancer Res Treat; 2012 Jul; 134(1):237-44. PubMed ID: 22350732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.
    Ito M; Ishii G; Nagai K; Maeda R; Nakano Y; Ochiai A
    Chest; 2012 Jul; 142(1):151-158. PubMed ID: 22302300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma.
    Kawase A; Ishii G; Nagai K; Ito T; Nagano T; Murata Y; Hishida T; Nishimura M; Yoshida J; Suzuki K; Ochiai A
    Int J Cancer; 2008 Sep; 123(5):1053-9. PubMed ID: 18546264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podoplanin expression is correlated with the prognosis of lung squamous cell carcinoma.
    Ikoma Y; Kijima H; Masuda R; Tanaka M; Inokuchi S; Iwazaki M
    Biomed Res; 2015; 36(6):393-402. PubMed ID: 26700593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podoplanin-positive cancer-associated fibroblast recruitment within cancer stroma is associated with a higher number of single nucleotide variants in cancer cells in lung adenocarcinoma.
    Nakasone S; Mimaki S; Ichikawa T; Aokage K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Tsuboi M; Goto K; Tsuchihara K; Ishii G
    J Cancer Res Clin Oncol; 2018 May; 144(5):893-900. PubMed ID: 29511884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma.
    Pula B; Jethon A; Piotrowska A; Gomulkiewicz A; Owczarek T; Calik J; Wojnar A; Witkiewicz W; Rys J; Ugorski M; Dziegiel P; Podhorska-Okolow M
    Histopathology; 2011 Dec; 59(6):1249-60. PubMed ID: 22175904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoid culture containing cancer cells and stromal cells reveals that podoplanin-positive cancer-associated fibroblasts enhance proliferation of lung cancer cells.
    Nakamura H; Sugano M; Miyashita T; Hashimoto H; Ochiai A; Suzuki K; Tsuboi M; Ishii G
    Lung Cancer; 2019 Aug; 134():100-107. PubMed ID: 31319967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung.
    Matsuoka Y; Takagi Y; Nosaka K; Sakabe T; Haruki T; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
    Histopathology; 2016 Jul; 69(1):114-20. PubMed ID: 27297724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of podoplanin and fibroblast growth factor 1 predicts poor prognosis in patients with lung squamous cell carcinoma.
    Li J; Chen H; Li X; Wang L; Gao A; Zhang P; Lin W; Gao W; Yang D; Guo X; Liu J; Dang Q; Sun Y
    Mol Med Rep; 2017 Aug; 16(2):1643-1652. PubMed ID: 28656229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal podoplanin expression and its clinicopathological role in breast carcinoma.
    Kumcu E; Unverdi H; Kaymaz E; Oral O; Turkbey D; Hucmenoglu S
    Malays J Pathol; 2018 Aug; 40(2):137-142. PubMed ID: 30173230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High podoplanin expression in cancer cells predicts lower incidence of nodal metastasis in patients with lung squamous cell carcinoma.
    Suzuki H; Onimaru M; Koga T; Takeshita M; Yano T; Maehara Y; Nakamura S; Sueishi K
    Pathol Res Pract; 2011 Feb; 207(2):111-5. PubMed ID: 21194851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies.
    Ito T; Ishii G; Nagai K; Nagano T; Kojika M; Murata Y; Atsumi N; Nishiwaki Y; Miyazaki E; Kumamoto T; Ochiai A
    Lung Cancer; 2009 Mar; 63(3):418-24. PubMed ID: 18657337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis.
    Hu L; Zhang P; Mei Q; Sun W; Zhou L; Yin T
    BMC Cancer; 2020 May; 20(1):424. PubMed ID: 32408907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.